WEDNESDAY, Oct. 6, 2021 (HealthDay News) — Since the rise of the Delta variant, one Texas hospital has seen a surge in severe COVID-19 among pregnant women — nearly all unvaccinated. Researchers at the Dallas hospital found that in late August and early September, 10% to 15% of pregnant patients
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — Almost 200,000 Ellume COVID-19 home testing kits have been recalled because they may be more likely to give a false positive result. The problem with the rapid antigen tests was identified in mid-September and caused by variations in the quality of one of
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — The rings of stately pines on the coasts of North and South Carolina offer telling long-term evidence of climate change and a chilling forecast for the future. The upshot: The last 300 years have gotten wetter and wetter, making hurricanes ever more dangerous.
TUESDAY, Oct. 5, 2021 (HealthDay News) — Full vaccination with the two-dose Pfizer COVID-19 vaccine has been 90% effective in protecting against hospitalization for at least six months, a new study shows. That includes the time during which the highly contagious Delta variant has been circulating in the United States.
TUESDAY, Oct. 5, 2021 (HealthDay News) — Misinformation and medical mistrust are major drivers of vaccine hesitancy among U.S. Hispanics, new research shows. The researchers also found that protecting other family members is an important factor in convincing Hispanics to get vaccinated. The small study included 22 Hispanic mothers in
TUESDAY, Oct. 5, 2021 (HealthDay News) — The ongoing coronavirus pandemic has hit minority groups in the United States hard, with significantly more deaths among Black and Hispanic Americans compared with white and Asian Americans, a new study finds. According to the report, these disparities highlight the need to address
MONDAY, Oct. 4, 2021 (HealthDay News) — Booster shots of the Pfizer-BioNTech coronavirus vaccine for people aged 18 and older have been given the green light by the European Medicines Agency. They “may be considered at least six months after the second dose for people aged 18 years and older,”
MONDAY, Oct. 4, 2021 (HealthDay News) — People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic. At least three contenders are vying to become the first antiviral
FRIDAY, Oct. 1, 2021 (HealthDay News) — One-quarter of U.S. parents report that their child has had to quarantine because of possible COVID-19 exposure since school started, a new poll finds. The nationally representative survey of 1,519 people conducted between Sept. 13 and Sept. 22 included 414 people who identified
FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly after
THURSDAY, Sept. 30, 2021 (HealthDay News) — The country’s leading health agency on Wednesday implored all Americans who are pregnant, breastfeeding or planning to become pregnant to get a coronavirus vaccine. COVID-19 poses a serious risk to women who are expecting, since they are vulnerable because of pregnancy’s dampening effect
THURSDAY, Sept. 30, 2021 (HealthDay News) — Artificial intelligence (AI) might be able to spot the next virus to jump from animals to humans, Scottish researchers report. Identifying diseases before they become a threat to humans is challenging, because only a few of the nearly 2 million animal viruses can